• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Introduction to 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine (CAS No. 66367-67-7) and Its Emerging Applications in Chemical Biology

4-Methyl-5-phenyl-2H-pyrazol-3-ylamine, identified by the chemical identifier CAS No. 66367-67-7, is a heterocyclic organic compound that has garnered significant attention in the field of chemical biology due to its unique structural properties and potential biological activities. This compound belongs to the pyrazole class, a scaffold that is widely recognized for its versatility in pharmaceutical and agrochemical applications. The presence of both methyl and phenyl substituents in its molecular structure contributes to its distinct electronic and steric characteristics, making it a valuable candidate for further investigation.

The pyrazole core of 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine is a six-membered aromatic ring containing two nitrogen atoms at positions 1 and 5. This structural motif is known to exhibit a wide range of biological interactions, including binding to enzymes, receptors, and other biomolecules. The methyl group at position 4 and the phenyl group at position 5 further modulate the compound's reactivity and binding affinity, making it an attractive scaffold for drug discovery efforts.

In recent years, there has been a surge in research focused on developing novel therapeutic agents derived from pyrazole derivatives. The compound 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine has been studied for its potential role in modulating various biological pathways, particularly those involving inflammation, neurodegeneration, and cancer. Its ability to interact with multiple targets makes it a promising candidate for the development of multifunctional drugs that can address complex diseases.

One of the most compelling aspects of 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine is its structural flexibility, which allows for facile derivatization to generate libraries of compounds with tailored biological properties. This has led to its exploration in high-throughput screening campaigns aimed at identifying novel bioactive molecules. The compound's ability to serve as a precursor for more complex structures has also made it valuable in synthetic chemistry research.

Recent studies have highlighted the potential of 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine as an inhibitor of specific enzymes implicated in disease pathways. For instance, research has suggested that derivatives of this compound may exhibit inhibitory effects on kinases and other enzymes involved in signal transduction. These findings are particularly intriguing given the critical role of aberrant signaling in conditions such as cancer and inflammatory disorders.

The pharmacokinetic properties of 4-Methyl-5-phenyl-2H-pyrazol-3-ylamine have also been subjects of interest. Studies indicate that this compound exhibits reasonable solubility and stability under physiological conditions, which are essential attributes for any drug candidate. Furthermore, preliminary toxicity studies have shown that it is well-tolerated at therapeutic doses, suggesting its potential for safe clinical application.

The synthesis of 4-Methyl-5-phenyl-2H-pyrazol-3-yamine involves multi-step organic reactions that highlight the ingenuity of modern synthetic methodologies. The process typically begins with the formation of the pyrazole core through condensation reactions between appropriate precursors. Subsequent functionalization steps introduce the methyl and phenyl groups at designated positions on the ring. These synthetic routes have been optimized to ensure high yields and purity, which are crucial for subsequent biological evaluation.

The versatility of 4-Methyl-(CAS No: 66367)-67) as a building block for more complex molecules has been demonstrated through various chemical transformations. For example, it can be alkylated, acylated, or undergo other functional group modifications to produce derivatives with enhanced biological activity or improved pharmacokinetic profiles. This adaptability makes it an indispensable tool in medicinal chemistry laboratories worldwide.

The growing body of literature on 4-Methyl-(CAS No: 66367)-67) underscores its significance as a pharmacophore in drug discovery. Researchers are increasingly leveraging this compound to develop novel therapeutics targeting a broad spectrum of diseases. Its unique combination of structural features and biological potential positions it as a cornerstone in the quest for innovative treatments.

In conclusion,(CAS No: 66367)-67) represents a fascinating example of how structural diversity can be harnessed to unlock new therapeutic opportunities. Its role in ongoing research highlights the importance of heterocyclic compounds like pyrazoles in addressing contemporary challenges in medicine and biology. As our understanding of its properties continues to expand,(CAS No: 66367)-67) is poised to play an even greater role in shaping the future landscape of drug discovery and development.

• 1093060-47-9(3-(4-fluorophenyl)-4-methyl-1H-pyrazol-5-amine)
• 1093060-49-1(3-(4-Chlorophenyl)-4-methyl-1H-pyrazol-5-amine)
• 1093060-48-0(4-methyl-3-(3-methylphenyl)-1H-pyrazol-5-amine)
• 42754-61-0(1H-Pyrazole-4-carbonitrile,3-amino-5-phenyl-)
• 890014-38-7(4-Methyl-5-phenyl-2H-pyrazol-3-ylamine)
• 103492-41-7(4-Methyl-5-phenyl-2h-pyrazol-3-ylamine hydrochloride)
• 1238871-01-6(4-methyl-3-phenyl-1H-pyrazol-5-amine hydrochloride)
• 63633-46-5(3,4-Diphenyl-1H-pyrazol-5-amine)
• 2145474-02-6(3-phenyl-4-(propan-2-yl)-1H-pyrazol-5-amine)
• 1239470-36-0(4-Methyl-3-(3-methylphenyl)-1H-pyrazol-5-amine hydrochloride)